Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
No Priors: Artificial Intelligence | Technology | Startups cover art

No Priors: Artificial Intelligence | Technology | Startups

No Priors: Artificial Intelligence | Technology | Startups

Written by: Conviction
Listen for free

About this listen
At this moment of inflection in technology, co-hosts Elad Gil and Sarah Guo talk to the world's leading AI engineers, researchers and founders about the biggest questions: How far away is AGI? What markets are at risk for disruption? How will commerce, culture, and society change? What’s happening in state-of-the-art in research? “No Priors” is your guide to the AI revolution. Email feedback to show@no-priors.com. Sarah Guo is a startup investor and the founder of Conviction, an investment firm purpose-built to serve intelligent software, or "Software 3.0" companies. She spent nearly a decade incubating and investing at venture firm Greylock Partners. Elad Gil is a serial entrepreneur and a startup investor. He was co-founder of Color Health, Mixer Labs (which was acquired by Twitter). He has invested in over 40 companies now worth $1B or more each, and is also author of the High Growth Handbook.© Copyright 2023 Conviction. All Rights Reserved. Economics Leadership Management & Leadership Science
Episodes
  • Superintelligence Needs the Physical World with CEO and Co-Founder of Arda Bob McGrew
    Nov 19 2026
    Is the AI singularity actually coming? Bob McGrew, former Chief Research Officer at OpenAI, argues that superintelligence won’t arrive without changes in the physical world, and that the “hard takeoff” argument is wrong. Sarah Guo and Elad Gil sit down with Bob, an early key executive at Palantir who later led research at OpenAI. He is now CEO and co-founder of Arda, which is leveraging AI to make American manufacturing competitive. Bob explains why automating AI researchers is a one-time boost rather than a runaway loop, and why GPUs, compute, wet labs, and factories are the real bottlenecks. They cover Arda’s work with Anduril on everything from actuators to missiles to the Fury combat aircraft, why Arda is building “Cursor for manufacturing engineers”, and how the forward deployed engineering model really works. Plus, the big-picture future view: machines that make machines, self-replicating factories, and Bob’s answer to the Fermi paradox. Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @bobmcgrewai | @Arda_Industries Chapters: 00:00 – Trailer 00:05 – Bob McGrew Introduction 01:05 – Why work on the physical world during the AI revolution? 02:27 – Why the hard takeoff argument is wrong 05:48 – Labs or startups – who will win in robotics and biology? 13:00 – Why America designs products but doesn’t build them 16:33 – Who needs flexible automation: defense, consumer electronics, data centers 18:19 – Humanoid robots vs. robotic work cells 21:07 – Open-world vs. closed-world robotics 25:20 – Building with Anduril: from days to 90 minutes 28:59 – Palantir’s problem-first approach vs. OpenAI’s technology-first approach 33:15 – From dropping out of Stanford to joining OpenAI 37:13 – Why general robotics models suddenly work 40:28 – Implications for the robotics ecosystem 42:46 – On-device models, speed, and safety 44:18 – How forward deployed engineering really works 50:57 – Superintelligence out of the data center 53:41 – Self-replicating factories and Von Neumann probes 56:46 – Bob’s answer to the Fermi paradox 59:33 – Conclusion
    Show More Show Less
    1 hr
  • Powering AI-Driven Drug Discovery with President of Isomorphic Labs Max Jaderberg
    Nov 12 2026
    Drug discovery and development has long relied on expensive, time-consuming empirical trial and error. By shifting the discovery process onto computers, Isomorphic Labs wants to fundamentally change medicine from a process of discovery to one of precision engineering. Elad Gil sits down with Isomorphic’s president Max Jaderberg to discuss his vision for using predictive AI models to achieve experimental accuracy. Max details how the success of AlphaFold provided the first proof of concept that a deep learning model could generalize in the field of biology, and how an AI model’s compounding of learnings allows it to achieve generalizability with scale, thus greatly increasing the probability of success as well as speed in real world clinical trials. He also talks about evolving past the need for animal testing through in-silico models, Isomorphic’s focus on developing drug design engines that are agnostic of disease area, target class, and modality, why accurate molecule engineering unlocks the potential for multidrug cocktails that span complex biological pathways, and how he believes AI molecule optimization will improve both human lifespan and healthspan. Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @MaxJaderberg | @IsomorphicLabs Chapters: 00:00 – Trailer 00:45 – Max Jaderberg Introduction 01:24 – Isomorphic Origins 05:23 – Drug Discovery Stagnation 11:49 – Hiring at Isomorphic 14:35 – Bringing Drug Discovery Onto Computers 19:31 – Isomorphic’s Datasets 20:30 – Rethinking Endpoints 22:50 – External vs. Internal Dependences 23:57 – Automating Biologic Labs 26:22 – Internal Development vs. Partnerships 27:19 – Areas of Human Health Focus 29:21 – Multidrug Approaches 32:17 – Risk Appetite Variation 34:26 – Disease Treatment Outlook 35:42 – Human Longevity and Drug Development 39:16 – Conclusion
    Show More Show Less
    39 mins
  • Tokenization, Agentic Trading, Harmonic: Robinhood's Mission to Expand Ownership with CEO Vlad Tenev
    Nov 5 2026
    What does it mean to build wealth as an individual investor in today’s society, especially as gains continue to get concentrated into smaller groups of VCs or institutional investors? Robinhood’s CEO and co-founder Vlad Tenev has a vision that can be summed up in one word: Ownership. In this episode, Sarah Guo chats with Vlad to get a closer look at how Robinhood has evolved from a simple app to buy stocks at zero commission into a global conglomerate that allows customers to own across a wide variety of surfaces and asset classes. Vlad explains how Robinhood is helping users extend ownership amidst the current economy and ongoing AI revolution through Trump accounts, tokenization of privates, and newer product offerings like Robinhood Chain, Agentic Trading, and Agentic Credit Card. He also talks about how his new mathematical superintelligence startup, Harmonic, is revolutionizing the field and how he hopes it will decentralize new discoveries and inventions. Vlad and Sarah also discuss how prediction markets could tie into the ownership conversation, whether financial infrastructure can be optimized to enable even higher volumes of high-frequency trading, and his advice for maintaining a level head when facing the vagaries of a changing financial market. Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @vladtenev | @RobinhoodApp | @HarmonicMath Chapters: 00:46 – Intro to Vlad Tenev, His Background, and Robinhood Today 12:25 – A Revolutionary Future for Mathematics 18:49 – Robinhood’s Vision for Tokenization 26:06 – Monetizing Knowledge via Prediction Markets 28:48 – Impacts of Agentic Trading and Democratizing Trading 33:48 – Safeguarding Financial Infrastructure for a New Load of HFTs 38:30 – Ownership of Private Companies in the AI Revolution 48:34 – Robinhood and Trump Accounts 50:47 – Keeping a Steady Hand and Head as a Leader 53:48 – Conclusion
    Show More Show Less
    54 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet